Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,428,955
-$6,998,420 QoQ
Shares Held
1,498,591
0.0% QoQ
Ownership
0.430%
of shares outstanding
% of Portfolio
3.84%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Knoll Capital Management, LLC holds $47,601,746 across 9 Biotechnology names. NUVB ranks #5 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MGTX |
MeiraGTx Holdings plc
|
1,250,000 | $10,825,000 | |
| 2 | ALDX |
Aldeyra Therapeutics, Inc.
|
5,475,516 | $9,253,622 | |
| 3 | ELTX |
Elicio Therapeutics, Inc.
|
630,915 | $6,744,481 | |
| 4 | ENTX |
Entera Bio Ltd.
|
5,881,879 | $6,528,885 | |
| 5 | NUVB |
Nuvation Bio Inc.
This page
|
1,498,591 | $6,428,955 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
600,400 | $5,085,388 | |
| 7 | ABEO |
Abeona Therapeutics Inc.
|
485,515 | $2,175,107 | |
| 8 | ALT |
Altimmune, Inc.
|
160,000 | $492,800 |
All Filings in NUVB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,428,955 | 1,498,591 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,427,375 | 1,498,591 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,792,500 | 1,025,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,998,750 | 1,025,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,804,000 | 1,025,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||